Leptin alters energy intake and fat mass but not energy expenditure in lean subjects

Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 11; no. 1; pp. 5145 - 15
Main Authors Chrysafi, Pavlina, Perakakis, Nikolaos, Farr, Olivia M., Stefanakis, Konstantinos, Peradze, Natia, Sala-Vila, Aleix, Mantzoros, Christos S.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 13.10.2020
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in humans. We thus performed detailed novel measurements and analyses of samples and data from our clinical trials biobank to investigate leptin effects on mechanisms of weight regulation in lean normo- and mildly hypo-leptinemic individuals without genetic disorders. We demonstrate that short-term leptin administration alters food intake during refeeding after fasting, whereas long-term leptin treatment reduces fat mass and body weight, and transiently alters circulating free fatty acids in lean mildly hypoleptinemic individuals. Leptin levels before treatment initiation and leptin dose do not predict the observed weight loss in lean individuals suggesting a saturable effect of leptin. In contrast to data from animal studies, leptin treatment does not affect energy expenditure, lipid utilization, SNS activity, heart rate, blood pressure or lean body mass. Leptin treatment is effective to reduce body weight in animal models, but patients with obesity and associated hyperleptinemia do not respond well to leptin therapy. Here the authors report a retrospective analysis of four clinical trials in normo- and mildly hypoleptinemic individuals and show that leptin therapy alters food intake in the short term and reduces weight and fat mass in the long term without effects on energy expenditure.
AbstractList Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in humans. We thus performed detailed novel measurements and analyses of samples and data from our clinical trials biobank to investigate leptin effects on mechanisms of weight regulation in lean normo- and mildly hypo-leptinemic individuals without genetic disorders. We demonstrate that short-term leptin administration alters food intake during refeeding after fasting, whereas long-term leptin treatment reduces fat mass and body weight, and transiently alters circulating free fatty acids in lean mildly hypoleptinemic individuals. Leptin levels before treatment initiation and leptin dose do not predict the observed weight loss in lean individuals suggesting a saturable effect of leptin. In contrast to data from animal studies, leptin treatment does not affect energy expenditure, lipid utilization, SNS activity, heart rate, blood pressure or lean body mass. Leptin treatment is effective to reduce body weight in animal models, but patients with obesity and associated hyperleptinemia do not respond well to leptin therapy. Here the authors report a retrospective analysis of four clinical trials in normo- and mildly hypoleptinemic individuals and show that leptin therapy alters food intake in the short term and reduces weight and fat mass in the long term without effects on energy expenditure.
Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in humans. We thus performed detailed novel measurements and analyses of samples and data from our clinical trials biobank to investigate leptin effects on mechanisms of weight regulation in lean normo- and mildly hypo-leptinemic individuals without genetic disorders. We demonstrate that short-term leptin administration alters food intake during refeeding after fasting, whereas long-term leptin treatment reduces fat mass and body weight, and transiently alters circulating free fatty acids in lean mildly hypoleptinemic individuals. Leptin levels before treatment initiation and leptin dose do not predict the observed weight loss in lean individuals suggesting a saturable effect of leptin. In contrast to data from animal studies, leptin treatment does not affect energy expenditure, lipid utilization, SNS activity, heart rate, blood pressure or lean body mass.
Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in humans. We thus performed detailed novel measurements and analyses of samples and data from our clinical trials biobank to investigate leptin effects on mechanisms of weight regulation in lean normo- and mildly hypo-leptinemic individuals without genetic disorders. We demonstrate that short-term leptin administration alters food intake during refeeding after fasting, whereas long-term leptin treatment reduces fat mass and body weight, and transiently alters circulating free fatty acids in lean mildly hypoleptinemic individuals. Leptin levels before treatment initiation and leptin dose do not predict the observed weight loss in lean individuals suggesting a saturable effect of leptin. In contrast to data from animal studies, leptin treatment does not affect energy expenditure, lipid utilization, SNS activity, heart rate, blood pressure or lean body mass.Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in humans. We thus performed detailed novel measurements and analyses of samples and data from our clinical trials biobank to investigate leptin effects on mechanisms of weight regulation in lean normo- and mildly hypo-leptinemic individuals without genetic disorders. We demonstrate that short-term leptin administration alters food intake during refeeding after fasting, whereas long-term leptin treatment reduces fat mass and body weight, and transiently alters circulating free fatty acids in lean mildly hypoleptinemic individuals. Leptin levels before treatment initiation and leptin dose do not predict the observed weight loss in lean individuals suggesting a saturable effect of leptin. In contrast to data from animal studies, leptin treatment does not affect energy expenditure, lipid utilization, SNS activity, heart rate, blood pressure or lean body mass.
Leptin treatment is effective to reduce body weight in animal models, but patients with obesity and associated hyperleptinemia do not respond well to leptin therapy. Here the authors report a retrospective analysis of four clinical trials in normo- and mildly hypoleptinemic individuals and show that leptin therapy alters food intake in the short term and reduces weight and fat mass in the long term without effects on energy expenditure.
ArticleNumber 5145
Author Peradze, Natia
Farr, Olivia M.
Sala-Vila, Aleix
Chrysafi, Pavlina
Perakakis, Nikolaos
Stefanakis, Konstantinos
Mantzoros, Christos S.
Author_xml – sequence: 1
  givenname: Pavlina
  surname: Chrysafi
  fullname: Chrysafi, Pavlina
  organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School
– sequence: 2
  givenname: Nikolaos
  orcidid: 0000-0002-2319-6603
  surname: Perakakis
  fullname: Perakakis, Nikolaos
  organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School
– sequence: 3
  givenname: Olivia M.
  surname: Farr
  fullname: Farr, Olivia M.
  organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School
– sequence: 4
  givenname: Konstantinos
  surname: Stefanakis
  fullname: Stefanakis, Konstantinos
  organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School
– sequence: 5
  givenname: Natia
  surname: Peradze
  fullname: Peradze, Natia
  organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School
– sequence: 6
  givenname: Aleix
  surname: Sala-Vila
  fullname: Sala-Vila, Aleix
  organization: Barcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM)
– sequence: 7
  givenname: Christos S.
  orcidid: 0000-0003-3755-8158
  surname: Mantzoros
  fullname: Mantzoros, Christos S.
  email: cmantzor@bidmc.harvard.edu
  organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School
BookMark eNp9kctuFDEQRS0URELID7Dykk0TP8f2BglFPCKNxCasreru8uChxx5sNyJ_n55MggiLeGOrfO-pKt3X5CTlhIS85ew9Z9JeVsXVynRMsI5ba3XnXpAzwRTvuBHy5J_3KbmodcuWIx23Sr0ip1IyzZV2Z-RmjfsWE4WpYakUE5bNLY2pwU-kkEYaoNEd1Er7udGU26ME_-wxjbHNBRc5nRASrXO_xaHVN-RlgKnixcN9Tr5__nRz9bVbf_tyffVx3Q3KutZprk0YV0pwE6xzEPQIJjgTtLYjaKVlL3uhhNF6cGGFZhQhMA4gUQpmnTwn10fumGHr9yXuoNz6DNHfF3LZeCgtDhN6q_gCNUr0A1cSjHVs1AqZDAK5BLuwPhxZ-7nf4ThgagWmJ9CnPyn-8Jv82y_TSSfEAnj3ACj514y1-V2sA04TJMxz9UJpziUX7iAVR-lQcq0Fw982nPlDuv6Yrl_S9ffp-sOy9j_TEBu0mA_jxOl5qzxa69InbbD4bZ5LWqJ5znUHWq252Q
CitedBy_id crossref_primary_10_3390_metabo14040221
crossref_primary_10_1080_08820139_2022_2129381
crossref_primary_10_1080_10641963_2022_2071920
crossref_primary_10_1590_s0004_2803_202302022_96
crossref_primary_10_1186_s40795_022_00531_w
crossref_primary_10_3390_ijms21249368
crossref_primary_10_3390_antiox13121485
crossref_primary_10_35378_gujs_1422409
crossref_primary_10_1016_j_cmet_2023_02_008
crossref_primary_10_1210_clinem_dgab517
crossref_primary_10_1016_j_clnu_2025_01_014
crossref_primary_10_1016_j_neubiorev_2022_104807
crossref_primary_10_1084_jem_20191593
crossref_primary_10_3389_fimmu_2024_1481312
crossref_primary_10_3389_fnut_2022_1002619
crossref_primary_10_1249_MSS_0000000000003518
crossref_primary_10_3390_cells12030407
crossref_primary_10_1016_j_metabol_2022_155265
crossref_primary_10_1016_j_metabol_2024_155984
crossref_primary_10_1021_acsptsci_3c00301
crossref_primary_10_1111_liv_15847
crossref_primary_10_1016_j_metabol_2023_155689
crossref_primary_10_1210_clinem_dgab269
crossref_primary_10_1515_hmbci_2022_0020
crossref_primary_10_1007_s11248_021_00288_1
crossref_primary_10_1038_s41366_021_00972_6
crossref_primary_10_1210_endrev_bnac015
crossref_primary_10_1016_j_molmet_2024_102078
crossref_primary_10_1210_clinem_dgab782
crossref_primary_10_1016_j_crbiot_2024_100204
crossref_primary_10_1038_s41467_024_49366_y
crossref_primary_10_3390_ijms23073965
crossref_primary_10_3390_biom13060972
crossref_primary_10_1016_j_neubiorev_2023_105164
crossref_primary_10_1016_j_jacc_2020_11_069
crossref_primary_10_1093_psyrad_kkad023
crossref_primary_10_1016_j_foodres_2023_112550
crossref_primary_10_1038_s41598_021_98605_5
crossref_primary_10_1007_s11154_021_09687_5
crossref_primary_10_3389_fnut_2022_809865
crossref_primary_10_3390_nu13041216
crossref_primary_10_1210_endrev_bnab034
crossref_primary_10_1002_prp2_70027
crossref_primary_10_1111_dom_16194
crossref_primary_10_1186_s10020_023_00702_w
crossref_primary_10_1177_09731296231198316
crossref_primary_10_1016_j_metabol_2024_156053
crossref_primary_10_1159_000527386
crossref_primary_10_1038_s41390_023_02632_z
crossref_primary_10_1111_brv_13039
crossref_primary_10_1016_j_pharmthera_2022_108284
crossref_primary_10_3390_biom13030470
crossref_primary_10_1016_j_metabol_2024_156056
crossref_primary_10_1186_s12929_022_00796_0
crossref_primary_10_3389_fpsyg_2022_885274
crossref_primary_10_1210_endrev_bnae011
crossref_primary_10_1080_1028415X_2022_2161135
crossref_primary_10_1007_s00787_021_01778_7
crossref_primary_10_22141_2224_0721_18_8_2022_1220
crossref_primary_10_1165_rcmb_2021_0199ED
Cites_doi 10.1161/CIRCGENETICS.114.000216
10.1056/NEJMoa040388
10.1172/JCI200317490
10.1038/s41591-019-0370-1
10.1007/s11306-007-0082-2
10.1126/science.7624776
10.1210/jendso/bvz022
10.1038/s41467-019-13721-1
10.1210/jcem.85.11.6955
10.1038/msb.2010.93
10.1249/MSS.0b013e31821ece12
10.1038/s41591-019-0722-x
10.1111/j.1463-1326.2005.00468.x
10.1007/BF00585195
10.1001/jama.282.16.1568
10.2337/diabetes.48.9.1787
10.1039/b910205a
10.1172/JCI0215693
10.1152/ajpregu.00045.2016
10.1038/sj.ijo.0802431
10.1210/jc.2012-3009
10.1016/j.cyto.2018.10.012
10.1038/s41467-019-12703-7
10.1038/s42255-019-0095-y
10.1016/j.ecl.2012.04.017
10.1038/s41467-019-11311-9
10.1161/01.HYP.37.3.936
10.1172/JCI25977
10.1038/382250a0
10.1038/s41467-019-13770-6
10.1016/j.cell.2017.12.001
10.1210/jc.2005-1545
10.1111/j.1749-6632.2002.tb04517.x
10.1093/ajcn/74.4.426
10.1038/s41467-019-13870-3
10.1038/sj.mp.4000418
10.1530/EJE-11-0252
10.2337/db10-1791
10.1073/pnas.0505429103
10.1172/JCI122042
10.2337/db15-1550
10.1073/pnas.0903723106
10.1016/j.cell.2015.08.055
10.1093/bioinformatics/bty528
10.1073/pnas.94.16.8878
10.1038/sj.ijo.0801952
10.1152/ajpendo.00546.2010
10.1001/jama.1992.03490120092034
10.2165/00003088-200847110-00006
10.1126/science.7624777
10.1038/s41598-017-16135-5
10.3945/ajcn.111.012385
10.1200/JCO.1999.17.10.3291
10.1007/s12020-018-1589-1
10.1038/ncomms11122
10.1056/NEJM199602013340503
10.1016/j.jacc.2017.12.006
10.2337/db18-296-LB
10.2337/db10-1302
10.1172/jci.insight.121434
10.1007/s12020-019-01862-8
10.1038/nm1295-1311
10.1056/NEJMoa012437
10.1002/oby.20433
10.1016/j.atherosclerosis.2020.03.028
10.1038/srep11189
10.1016/j.cmet.2017.05.013
10.1073/pnas.1015674108
10.1038/43448
10.1210/jc.2014-2774
10.1101/2020.07.02.20143685
10.1111/j.1365-2265.2006.02684.x
10.1016/S0022-2275(20)41345-8
10.1210/clinem/dgaa251
ContentType Journal Article
Copyright This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2020
Copyright_xml – notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2020
DBID C6C
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1038/s41467-020-18885-9
DatabaseName Springer Nature OA Free Journals
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList
CrossRef

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 15
ExternalDocumentID oai_doaj_org_article_84158d742bc143a7890d54e03f2e13a8
PMC7553922
10_1038_s41467_020_18885_9
GrantInformation_xml – fundername: The current study was funded by NIH K24DK081913. Ni.P. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) –389891681 (PE 2431/2-1). A.S.-V. is recipient of the Instituto de Salud Carlos III Miguel Servet fellowship (grant CP II 17/00029). P.C. received a 2018 Summer Research Fellowship (SRF) funded by the Endocrine Society to support participation in the research project.
– fundername: ;
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LK8
M1P
M48
M7P
M~E
NAO
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
7X8
AARCD
PJZUB
PPXIY
PQGLB
5PM
PUEGO
ID FETCH-LOGICAL-c489t-5157fd64217f899af5da7f97f558da5453b3b242755c9f6e7d2ff01aa3e320893
IEDL.DBID M48
ISSN 2041-1723
IngestDate Wed Aug 27 01:27:29 EDT 2025
Thu Aug 21 14:10:25 EDT 2025
Tue Aug 05 11:38:54 EDT 2025
Tue Jul 01 04:09:05 EDT 2025
Thu Apr 24 23:03:38 EDT 2025
Fri Feb 21 02:40:07 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c489t-5157fd64217f899af5da7f97f558da5453b3b242755c9f6e7d2ff01aa3e320893
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-2319-6603
0000-0003-3755-8158
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41467-020-18885-9
PMID 33051459
PQID 2451131292
PQPubID 23479
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_84158d742bc143a7890d54e03f2e13a8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7553922
proquest_miscellaneous_2451131292
crossref_primary_10_1038_s41467_020_18885_9
crossref_citationtrail_10_1038_s41467_020_18885_9
springer_journals_10_1038_s41467_020_18885_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-10-13
PublicationDateYYYYMMDD 2020-10-13
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-13
  day: 13
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationYear 2020
Publisher Nature Publishing Group UK
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Portfolio
References Satoh (CR43) 1999; 48
Wurtz, Soininen (CR75) 2020; 302
Heymsfield (CR14) 1999; 282
Mittendorfer (CR15) 2011; 60
Kaklamani (CR54) 1999; 17
Zelissen (CR21) 2005; 7
Steinhauser (CR34) 2018; 3
Zuber, Colijn, Klaver, Burgess (CR68) 2020; 11
Hukshorn (CR20) 2002; 26
Holmes (CR74) 2018; 71
Wu (CR4) 2010; 39
Mackowiak, Wasserman, Levine (CR32) 1992; 268
Korner (CR45) 2013; 21
CR77
Hukshorn (CR19) 2000; 85
Perry (CR35) 2018; 172
Inouye (CR67) 2010; 6
Correia, Morgan, Sivitz, Mark, Haynes (CR40) 2001; 37
Chan, Heist, DePaoli, Veldhuis, Mantzoros (CR26) 2003; 111
Gallois (CR71) 2019; 10
Halaas (CR6) 1995; 269
Westerterp-Plantenga, Saris, Hukshorn, Campfield (CR60) 2001; 74
Oral (CR31) 2002; 346
Friedman (CR25) 2019; 1
Farr (CR59) 2014; 99
Chong, Xia (CR79) 2018; 34
Sumner (CR64) 2007; 3
Soininen (CR66) 2009; 134
Shibuya (CR44) 2002; 971
Kettunen (CR73) 2016; 7
Clemmons (CR53) 2012; 41
Ahima (CR49) 1996; 382
Kissileff (CR46) 2012; 95
Vojinovic (CR70) 2019; 10
Chan (CR27) 2006; 103
Chan, Wong, Mantzoros (CR30) 2008; 47
Deelen (CR72) 2019; 10
Rosenbaum, Sy, Pavlovich, Leibel, Hirsch (CR48) 2008; 118
Halaas (CR9) 1997; 94
Pandit, Beerens, Adan (CR39) 2017; 312
DePaoli, Long, Fine, Stewart, O’Rahilly (CR23) 2018; 67
Hagenbeek (CR69) 2020; 11
Kirsten (CR55) 1977; 368
Lee, Chan, Sourlas, Raptopoulos, Mantzoros (CR12) 2006; 91
Moon (CR16) 2011; 60
Schlogl (CR58) 2016; 65
Lejeune, Hukshorn, Saris, Westerterp-Plantenga (CR22) 2003; 27
Zeng (CR8) 2015; 163
Machleidt (CR41) 2013; 98
Frederich (CR1) 1995; 1
Fogteloo, Pijl, Frolich, McCamish, Meinders (CR18) 2003; 16
Audi (CR5) 1998; 3
Chan, Mietus, Raciti, Goldberger, Mantzoros (CR62) 2007; 66
CR51
Singh (CR7) 2009; 106
Grewal (CR52) 2020; 4
Pelleymounter (CR37) 1995; 269
Boden, Chen, Mozzoli, Ryan (CR3) 1996; 81
Shimomura, Hammer, Ikemoto, Brown, Goldstein (CR56) 1999; 401
Rosenbaum (CR47) 2005; 115
Tang, Tang, Li, Wang (CR38) 2015; 5
Flier, Maratos-Flier (CR24) 2017; 26
Soininen, Kangas, Wurtz, Suna, Ala-Korpela (CR65) 2015; 8
Hwa (CR50) 1997; 272
Puschel (CR57) 2019; 113
Oral (CR13) 2019; 64
Agren, Julkunen, Penttila (CR78) 1992; 33
Liu (CR76) 2020; 26
Shetty (CR17) 2011; 165
Chou (CR28) 2011; 108
Ainsworth (CR63) 2011; 43
Welt (CR29) 2004; 351
Considine (CR2) 1996; 334
Gilgen-Ammann (CR33) 2017; 7
Rosenbaum, Leibel (CR36) 2018; 128
Morton (CR42) 2011; 300
Brown (CR10) 2018; 60
Farooqi (CR11) 2002; 110
Dallner (CR61) 2019; 25
ML Correia (18885_CR40) 2001; 37
F Machleidt (18885_CR41) 2013; 98
J Liu (18885_CR76) 2020; 26
HS Moon (18885_CR16) 2011; 60
M Rosenbaum (18885_CR48) 2008; 118
JH Lee (18885_CR12) 2006; 91
MA Pelleymounter (18885_CR37) 1995; 269
OS Dallner (18885_CR61) 2019; 25
M Inouye (18885_CR67) 2010; 6
GJ Morton (18885_CR42) 2011; 300
EA Oral (18885_CR31) 2002; 346
RJ Brown (18885_CR10) 2018; 60
JL Halaas (18885_CR6) 1995; 269
B Wu (18885_CR4) 2010; 39
I Shibuya (18885_CR44) 2002; 971
J Chong (18885_CR79) 2018; 34
CK Welt (18885_CR29) 2004; 351
M Rosenbaum (18885_CR36) 2018; 128
JJ Hwa (18885_CR50) 1997; 272
G Boden (18885_CR3) 1996; 81
LW Sumner (18885_CR64) 2007; 3
L Audi (18885_CR5) 1998; 3
JL Chan (18885_CR30) 2008; 47
J Kettunen (18885_CR73) 2016; 7
JL Chan (18885_CR26) 2003; 111
J Puschel (18885_CR57) 2019; 113
EA Oral (18885_CR13) 2019; 64
AJ Fogteloo (18885_CR18) 2003; 16
JS Flier (18885_CR24) 2017; 26
ML Steinhauser (18885_CR34) 2018; 3
V Zuber (18885_CR68) 2020; 11
P Soininen (18885_CR66) 2009; 134
RJ Perry (18885_CR35) 2018; 172
PM Zelissen (18885_CR21) 2005; 7
MV Holmes (18885_CR74) 2018; 71
A Singh (18885_CR7) 2009; 106
A Gallois (18885_CR71) 2019; 10
J Deelen (18885_CR72) 2019; 10
P Wurtz (18885_CR75) 2020; 302
GK Shetty (18885_CR17) 2011; 165
R Pandit (18885_CR39) 2017; 312
RV Considine (18885_CR2) 1996; 334
CJ Hukshorn (18885_CR20) 2002; 26
18885_CR51
JL Chan (18885_CR27) 2006; 103
FA Hagenbeek (18885_CR69) 2020; 11
VG Kaklamani (18885_CR54) 1999; 17
D Vojinovic (18885_CR70) 2019; 10
JJ Agren (18885_CR78) 1992; 33
GB Tang (18885_CR38) 2015; 5
MS Westerterp-Plantenga (18885_CR60) 2001; 74
JL Halaas (18885_CR9) 1997; 94
RC Frederich (18885_CR1) 1995; 1
JM Friedman (18885_CR25) 2019; 1
A DePaoli (18885_CR23) 2018; 67
CJ Hukshorn (18885_CR19) 2000; 85
B Mittendorfer (18885_CR15) 2011; 60
H Schlogl (18885_CR58) 2016; 65
J Korner (18885_CR45) 2013; 21
W Zeng (18885_CR8) 2015; 163
BE Ainsworth (18885_CR63) 2011; 43
N Satoh (18885_CR43) 1999; 48
DR Clemmons (18885_CR53) 2012; 41
I Shimomura (18885_CR56) 1999; 401
18885_CR77
SB Heymsfield (18885_CR14) 1999; 282
PA Mackowiak (18885_CR32) 1992; 268
JL Chan (18885_CR62) 2007; 66
P Soininen (18885_CR65) 2015; 8
RS Ahima (18885_CR49) 1996; 382
M Rosenbaum (18885_CR47) 2005; 115
SH Chou (18885_CR28) 2011; 108
IS Farooqi (18885_CR11) 2002; 110
HR Kissileff (18885_CR46) 2012; 95
S Grewal (18885_CR52) 2020; 4
OM Farr (18885_CR59) 2014; 99
MP Lejeune (18885_CR22) 2003; 27
R Kirsten (18885_CR55) 1977; 368
R Gilgen-Ammann (18885_CR33) 2017; 7
References_xml – volume: 8
  start-page: 192
  year: 2015
  end-page: 206
  ident: CR65
  article-title: Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics
  publication-title: Circ. Cardiovasc. Genet.
  doi: 10.1161/CIRCGENETICS.114.000216
– volume: 351
  start-page: 987
  year: 2004
  end-page: 997
  ident: CR29
  article-title: Recombinant human leptin in women with hypothalamic amenorrhea
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa040388
– volume: 111
  start-page: 1409
  year: 2003
  end-page: 1421
  ident: CR26
  article-title: The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI200317490
– volume: 25
  start-page: 507
  year: 2019
  end-page: 516
  ident: CR61
  article-title: Dysregulation of a long noncoding RNA reduces leptin leading to a leptin-responsive form of obesity
  publication-title: Nat. Med.
  doi: 10.1038/s41591-019-0370-1
– volume: 3
  start-page: 211
  year: 2007
  end-page: 221
  ident: CR64
  article-title: Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)
  publication-title: Metabolomics
  doi: 10.1007/s11306-007-0082-2
– volume: 269
  start-page: 540
  year: 1995
  end-page: 543
  ident: CR37
  article-title: Effects of the obese gene product on body weight regulation in ob/ob mice
  publication-title: Science
  doi: 10.1126/science.7624776
– volume: 4
  start-page: bvz022
  year: 2020
  ident: CR52
  article-title: Metabolomic analysis of the effects of leptin replacement therapy in patients with lipodystrophy
  publication-title: J. Endocr. Soc.
  doi: 10.1210/jendso/bvz022
– ident: CR51
– volume: 10
  year: 2019
  ident: CR70
  article-title: Relationship between gut microbiota and circulating metabolites in population-based cohorts
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-13721-1
– volume: 85
  start-page: 4003
  year: 2000
  end-page: 4009
  ident: CR19
  article-title: Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jcem.85.11.6955
– volume: 6
  start-page: 441
  year: 2010
  ident: CR67
  article-title: Metabonomic, transcriptomic, and genomic variation of a population cohort
  publication-title: Mol. Syst. Biol.
  doi: 10.1038/msb.2010.93
– volume: 43
  start-page: 1575
  year: 2011
  end-page: 1581
  ident: CR63
  article-title: 2011 Compendium of physical activities: a second update of codes and MET values
  publication-title: Med. Sci. sports Exerc.
  doi: 10.1249/MSS.0b013e31821ece12
– volume: 26
  start-page: 110
  year: 2020
  end-page: 117
  ident: CR76
  article-title: Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas
  publication-title: Nat. Med.
  doi: 10.1038/s41591-019-0722-x
– volume: 7
  start-page: 755
  year: 2005
  end-page: 761
  ident: CR21
  article-title: Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial
  publication-title: Diabetes, Obes. Metab.
  doi: 10.1111/j.1463-1326.2005.00468.x
– volume: 368
  start-page: 189
  year: 1977
  end-page: 194
  ident: CR55
  article-title: Effects of aldosterone on lipid metabolism and renal oxygen consumption in the rat
  publication-title: Pflug. Arch.
  doi: 10.1007/BF00585195
– volume: 282
  start-page: 1568
  year: 1999
  end-page: 1575
  ident: CR14
  article-title: Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial
  publication-title: J. Am. Med. Assoc.
  doi: 10.1001/jama.282.16.1568
– volume: 48
  start-page: 1787
  year: 1999
  end-page: 1793
  ident: CR43
  article-title: Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion
  publication-title: Diabetes
  doi: 10.2337/diabetes.48.9.1787
– ident: CR77
– volume: 134
  start-page: 1781
  year: 2009
  end-page: 1785
  ident: CR66
  article-title: High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism
  publication-title: Analyst
  doi: 10.1039/b910205a
– volume: 110
  start-page: 1093
  year: 2002
  end-page: 1103
  ident: CR11
  article-title: Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI0215693
– volume: 312
  start-page: R938
  year: 2017
  end-page: R947
  ident: CR39
  article-title: Role of leptin in energy expenditure: the hypothalamic perspective
  publication-title: Am. J. Physiol. Regul. Integr. Comp. Physiol.
  doi: 10.1152/ajpregu.00045.2016
– volume: 27
  start-page: 1494
  year: 2003
  end-page: 1499
  ident: CR22
  article-title: Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men
  publication-title: Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes.
  doi: 10.1038/sj.ijo.0802431
– volume: 39
  start-page: 601
  year: 2010
  end-page: 605
  ident: CR4
  article-title: Effect of repeated fasting/refeeding on body weight control and energy balance regulation in rats
  publication-title: Wei Sheng Yan Jiu
– volume: 98
  start-page: E491
  year: 2013
  end-page: E496
  ident: CR41
  article-title: Experimental hyperleptinemia acutely increases vasoconstrictory sympathetic nerve activity in healthy humans
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2012-3009
– volume: 113
  start-page: 400
  year: 2019
  end-page: 404
  ident: CR57
  article-title: Beneficial effects of leptin substitution on impaired eating behavior in lipodystrophy are sustained beyond 150 weeks of treatment
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2018.10.012
– volume: 10
  year: 2019
  ident: CR71
  article-title: A comprehensive study of metabolite genetics reveals strong pleiotropy and heterogeneity across time and context
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-12703-7
– volume: 1
  start-page: 754
  year: 2019
  end-page: 764
  ident: CR25
  article-title: Leptin and the endocrine control of energy balance
  publication-title: Nat. Metab.
  doi: 10.1038/s42255-019-0095-y
– volume: 41
  start-page: 425
  year: 2012
  end-page: 443
  ident: CR53
  article-title: Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes
  publication-title: Endocrinol. Metab. Clin. North Am.
  doi: 10.1016/j.ecl.2012.04.017
– volume: 10
  year: 2019
  ident: CR72
  article-title: A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-11311-9
– volume: 37
  start-page: 936
  year: 2001
  end-page: 942
  ident: CR40
  article-title: Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure
  publication-title: Hypertension
  doi: 10.1161/01.HYP.37.3.936
– volume: 115
  start-page: 3579
  year: 2005
  end-page: 3586
  ident: CR47
  article-title: Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI25977
– volume: 382
  start-page: 250
  year: 1996
  end-page: 252
  ident: CR49
  article-title: Role of leptin in the neuroendocrine response to fasting
  publication-title: Nature
  doi: 10.1038/382250a0
– volume: 11
  year: 2020
  ident: CR69
  article-title: Heritability estimates for 361 blood metabolites across 40 genome-wide association studies
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-13770-6
– volume: 66
  start-page: 49
  year: 2007
  end-page: 57
  ident: CR62
  article-title: Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans
  publication-title: Clin. Endocrinol.
– volume: 172
  start-page: 234
  year: 2018
  end-page: 248
  ident: CR35
  article-title: Leptin mediates a glucose-fatty acid cycle to maintain glucose homeostasis in starvation
  publication-title: Cell
  doi: 10.1016/j.cell.2017.12.001
– volume: 91
  start-page: 2605
  year: 2006
  end-page: 2611
  ident: CR12
  article-title: Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2005-1545
– volume: 971
  start-page: 522
  year: 2002
  end-page: 527
  ident: CR44
  article-title: Regulation of catecholamine synthesis by leptin
  publication-title: Ann. N. Y Acad. Sci.
  doi: 10.1111/j.1749-6632.2002.tb04517.x
– volume: 74
  start-page: 426
  year: 2001
  end-page: 434
  ident: CR60
  article-title: Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/74.4.426
– volume: 11
  year: 2020
  ident: CR68
  article-title: Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-13870-3
– volume: 3
  start-page: 544
  year: 1998
  end-page: 547
  ident: CR5
  article-title: Leptin in relation to resumption of menses in women with anorexia nervosa
  publication-title: Mol. Psychiatry
  doi: 10.1038/sj.mp.4000418
– volume: 165
  start-page: 249
  year: 2011
  end-page: 254
  ident: CR17
  article-title: Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet
  publication-title: Eur. J. Endocrinol.
  doi: 10.1530/EJE-11-0252
– volume: 60
  start-page: 1647
  year: 2011
  end-page: 1656
  ident: CR16
  article-title: Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance
  publication-title: Diabetes
  doi: 10.2337/db10-1791
– volume: 103
  start-page: 8481
  year: 2006
  end-page: 8486
  ident: CR27
  article-title: Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0505429103
– volume: 128
  start-page: 3237
  year: 2018
  end-page: 3239
  ident: CR36
  article-title: Physiological responses to leptin levels in lipodystrophy: a model for other hypoleptinemias?
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI122042
– volume: 65
  start-page: 2179
  year: 2016
  end-page: 2186
  ident: CR58
  article-title: Leptin substitution in patients with lipodystrophy: neural correlates for long-term success in the normalization of eating behavior
  publication-title: Diabetes
  doi: 10.2337/db15-1550
– volume: 106
  start-page: 13100
  year: 2009
  end-page: 13105
  ident: CR7
  article-title: Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0903723106
– volume: 163
  start-page: 84
  year: 2015
  end-page: 94
  ident: CR8
  article-title: Sympathetic neuro-adipose connections mediate leptin-driven lipolysis
  publication-title: Cell
  doi: 10.1016/j.cell.2015.08.055
– volume: 34
  start-page: 4313
  year: 2018
  end-page: 4314
  ident: CR79
  article-title: MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bty528
– volume: 81
  start-page: 3419
  year: 1996
  end-page: 3423
  ident: CR3
  article-title: Effect of fasting on serum leptin in normal human subjects
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 94
  start-page: 8878
  year: 1997
  end-page: 8883
  ident: CR9
  article-title: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.94.16.8878
– volume: 26
  start-page: 504
  year: 2002
  end-page: 509
  ident: CR20
  article-title: The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects
  publication-title: Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes.
  doi: 10.1038/sj.ijo.0801952
– volume: 300
  start-page: E392
  year: 2011
  end-page: E401
  ident: CR42
  article-title: Identification of a physiological role for leptin in the regulation of ambulatory activity and wheel running in mice
  publication-title: Am. J. Physiol. Endocrinol. Metab.
  doi: 10.1152/ajpendo.00546.2010
– volume: 16
  start-page: 109
  year: 2003
  end-page: 114
  ident: CR18
  article-title: Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans
  publication-title: Diabetes, Nutr. Metab.
– volume: 268
  start-page: 1578
  year: 1992
  end-page: 1580
  ident: CR32
  article-title: A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich
  publication-title: J. Am. Med. Assoc.
  doi: 10.1001/jama.1992.03490120092034
– volume: 47
  start-page: 753
  year: 2008
  end-page: 764
  ident: CR30
  article-title: Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity
  publication-title: Clin. Pharmacokinetics
  doi: 10.2165/00003088-200847110-00006
– volume: 269
  start-page: 543
  year: 1995
  end-page: 546
  ident: CR6
  article-title: Weight-reducing effects of the plasma protein encoded by the obese gene
  publication-title: Science
  doi: 10.1126/science.7624777
– volume: 7
  year: 2017
  ident: CR33
  article-title: Energy expenditure estimation from respiration variables
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-16135-5
– volume: 95
  start-page: 309
  year: 2012
  end-page: 317
  ident: CR46
  article-title: Leptin reverses declines in satiation in weight-reduced obese humans
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.111.012385
– volume: 17
  start-page: 3291
  year: 1999
  end-page: 3298
  ident: CR54
  article-title: Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.1999.17.10.3291
– volume: 60
  start-page: 479
  year: 2018
  end-page: 489
  ident: CR10
  article-title: Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
  publication-title: Endocrine
  doi: 10.1007/s12020-018-1589-1
– volume: 7
  year: 2016
  ident: CR73
  article-title: Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms11122
– volume: 334
  start-page: 292
  year: 1996
  end-page: 295
  ident: CR2
  article-title: Serum immunoreactive-leptin concentrations in normal-weight and obese humans
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199602013340503
– volume: 71
  start-page: 620
  year: 2018
  end-page: 632
  ident: CR74
  article-title: Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2017.12.006
– volume: 67
  start-page: 296
  year: 2018
  ident: CR23
  article-title: Efficacy of metreleptin for weight loss in overweight and obese adults with low leptin levels
  publication-title: Diabetes
  doi: 10.2337/db18-296-LB
– volume: 60
  start-page: 1474
  year: 2011
  end-page: 1477
  ident: CR15
  article-title: Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/db10-1302
– volume: 3
  start-page: e121434
  year: 2018
  ident: CR34
  article-title: The circulating metabolome of human starvation
  publication-title: JCI insight
  doi: 10.1172/jci.insight.121434
– volume: 64
  start-page: 500
  year: 2019
  end-page: 511
  ident: CR13
  article-title: Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy
  publication-title: Endocrine
  doi: 10.1007/s12020-019-01862-8
– volume: 1
  start-page: 1311
  year: 1995
  end-page: 1314
  ident: CR1
  article-title: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action
  publication-title: Nat. Med.
  doi: 10.1038/nm1295-1311
– volume: 346
  start-page: 570
  year: 2002
  end-page: 578
  ident: CR31
  article-title: Leptin-replacement therapy for lipodystrophy
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa012437
– volume: 21
  start-page: 951
  year: 2013
  end-page: 956
  ident: CR45
  article-title: Randomized double-blind placebo-controlled study of leptin administration after gastric bypass
  publication-title: Obesity
  doi: 10.1002/oby.20433
– volume: 302
  start-page: 59
  year: 2020
  end-page: 61
  ident: CR75
  article-title: Reply to: “Methodological issues regarding: “a third of nonfasting plasma cholesterol is in remnant lipoproteins: lipoprotein subclass profiling in 9293 individuals””
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2020.03.028
– volume: 5
  year: 2015
  ident: CR38
  article-title: Intracerebroventricular administration of leptin increase physical activity but has no effect on thermogenesis in cold-acclimated rats
  publication-title: Sci. Rep.
  doi: 10.1038/srep11189
– volume: 33
  start-page: 1871
  year: 1992
  end-page: 1876
  ident: CR78
  article-title: Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column
  publication-title: J. Lipid Res.
– volume: 272
  start-page: R1204
  year: 1997
  end-page: R1209
  ident: CR50
  article-title: Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice
  publication-title: Am. J. Physiol.
– volume: 26
  start-page: 24
  year: 2017
  end-page: 26
  ident: CR24
  article-title: Leptin’s physiologic role: does the emperor of energy balance have no clothes?
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2017.05.013
– volume: 118
  start-page: 2583
  year: 2008
  end-page: 2591
  ident: CR48
  article-title: Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli
  publication-title: J. Clin. Investig.
– volume: 108
  start-page: 6585
  year: 2011
  end-page: 6590
  ident: CR28
  article-title: Leptin is an effective treatment for hypothalamic amenorrhea
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1015674108
– volume: 401
  start-page: 73
  year: 1999
  end-page: 76
  ident: CR56
  article-title: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
  publication-title: Nature
  doi: 10.1038/43448
– volume: 99
  start-page: E2529
  year: 2014
  end-page: E2538
  ident: CR59
  article-title: Leptin therapy alters appetite and neural responses to food stimuli in brain areas of leptin-sensitive subjects without altering brain structure
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2014-2774
– volume: 95
  start-page: 309
  year: 2012
  ident: 18885_CR46
  publication-title: Am. J. Clin. Nutr.
  doi: 10.3945/ajcn.111.012385
– volume: 1
  start-page: 1311
  year: 1995
  ident: 18885_CR1
  publication-title: Nat. Med.
  doi: 10.1038/nm1295-1311
– volume: 163
  start-page: 84
  year: 2015
  ident: 18885_CR8
  publication-title: Cell
  doi: 10.1016/j.cell.2015.08.055
– volume: 269
  start-page: 540
  year: 1995
  ident: 18885_CR37
  publication-title: Science
  doi: 10.1126/science.7624776
– volume: 134
  start-page: 1781
  year: 2009
  ident: 18885_CR66
  publication-title: Analyst
  doi: 10.1039/b910205a
– volume: 60
  start-page: 479
  year: 2018
  ident: 18885_CR10
  publication-title: Endocrine
  doi: 10.1007/s12020-018-1589-1
– volume: 268
  start-page: 1578
  year: 1992
  ident: 18885_CR32
  publication-title: J. Am. Med. Assoc.
  doi: 10.1001/jama.1992.03490120092034
– volume: 71
  start-page: 620
  year: 2018
  ident: 18885_CR74
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2017.12.006
– volume: 7
  start-page: 755
  year: 2005
  ident: 18885_CR21
  publication-title: Diabetes, Obes. Metab.
  doi: 10.1111/j.1463-1326.2005.00468.x
– volume: 47
  start-page: 753
  year: 2008
  ident: 18885_CR30
  publication-title: Clin. Pharmacokinetics
  doi: 10.2165/00003088-200847110-00006
– volume: 25
  start-page: 507
  year: 2019
  ident: 18885_CR61
  publication-title: Nat. Med.
  doi: 10.1038/s41591-019-0370-1
– volume: 110
  start-page: 1093
  year: 2002
  ident: 18885_CR11
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI0215693
– volume: 971
  start-page: 522
  year: 2002
  ident: 18885_CR44
  publication-title: Ann. N. Y Acad. Sci.
  doi: 10.1111/j.1749-6632.2002.tb04517.x
– volume: 334
  start-page: 292
  year: 1996
  ident: 18885_CR2
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199602013340503
– volume: 81
  start-page: 3419
  year: 1996
  ident: 18885_CR3
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 27
  start-page: 1494
  year: 2003
  ident: 18885_CR22
  publication-title: Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes.
  doi: 10.1038/sj.ijo.0802431
– volume: 5
  year: 2015
  ident: 18885_CR38
  publication-title: Sci. Rep.
  doi: 10.1038/srep11189
– volume: 10
  year: 2019
  ident: 18885_CR71
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-12703-7
– volume: 26
  start-page: 24
  year: 2017
  ident: 18885_CR24
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2017.05.013
– volume: 272
  start-page: R1204
  year: 1997
  ident: 18885_CR50
  publication-title: Am. J. Physiol.
– volume: 10
  year: 2019
  ident: 18885_CR70
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-13721-1
– volume: 10
  year: 2019
  ident: 18885_CR72
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-11311-9
– volume: 3
  start-page: 544
  year: 1998
  ident: 18885_CR5
  publication-title: Mol. Psychiatry
  doi: 10.1038/sj.mp.4000418
– volume: 3
  start-page: 211
  year: 2007
  ident: 18885_CR64
  publication-title: Metabolomics
  doi: 10.1007/s11306-007-0082-2
– volume: 103
  start-page: 8481
  year: 2006
  ident: 18885_CR27
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0505429103
– volume: 172
  start-page: 234
  year: 2018
  ident: 18885_CR35
  publication-title: Cell
  doi: 10.1016/j.cell.2017.12.001
– volume: 26
  start-page: 110
  year: 2020
  ident: 18885_CR76
  publication-title: Nat. Med.
  doi: 10.1038/s41591-019-0722-x
– volume: 16
  start-page: 109
  year: 2003
  ident: 18885_CR18
  publication-title: Diabetes, Nutr. Metab.
– volume: 26
  start-page: 504
  year: 2002
  ident: 18885_CR20
  publication-title: Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes.
  doi: 10.1038/sj.ijo.0801952
– volume: 302
  start-page: 59
  year: 2020
  ident: 18885_CR75
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2020.03.028
– ident: 18885_CR77
  doi: 10.1101/2020.07.02.20143685
– volume: 91
  start-page: 2605
  year: 2006
  ident: 18885_CR12
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2005-1545
– volume: 115
  start-page: 3579
  year: 2005
  ident: 18885_CR47
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI25977
– volume: 368
  start-page: 189
  year: 1977
  ident: 18885_CR55
  publication-title: Pflug. Arch.
  doi: 10.1007/BF00585195
– volume: 60
  start-page: 1474
  year: 2011
  ident: 18885_CR15
  publication-title: Diabetes
  doi: 10.2337/db10-1302
– volume: 66
  start-page: 49
  year: 2007
  ident: 18885_CR62
  publication-title: Clin. Endocrinol.
  doi: 10.1111/j.1365-2265.2006.02684.x
– volume: 351
  start-page: 987
  year: 2004
  ident: 18885_CR29
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa040388
– volume: 11
  year: 2020
  ident: 18885_CR68
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-13870-3
– volume: 85
  start-page: 4003
  year: 2000
  ident: 18885_CR19
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jcem.85.11.6955
– volume: 300
  start-page: E392
  year: 2011
  ident: 18885_CR42
  publication-title: Am. J. Physiol. Endocrinol. Metab.
  doi: 10.1152/ajpendo.00546.2010
– volume: 17
  start-page: 3291
  year: 1999
  ident: 18885_CR54
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.1999.17.10.3291
– volume: 41
  start-page: 425
  year: 2012
  ident: 18885_CR53
  publication-title: Endocrinol. Metab. Clin. North Am.
  doi: 10.1016/j.ecl.2012.04.017
– volume: 64
  start-page: 500
  year: 2019
  ident: 18885_CR13
  publication-title: Endocrine
  doi: 10.1007/s12020-019-01862-8
– volume: 3
  start-page: e121434
  year: 2018
  ident: 18885_CR34
  publication-title: JCI insight
  doi: 10.1172/jci.insight.121434
– volume: 33
  start-page: 1871
  year: 1992
  ident: 18885_CR78
  publication-title: J. Lipid Res.
  doi: 10.1016/S0022-2275(20)41345-8
– volume: 401
  start-page: 73
  year: 1999
  ident: 18885_CR56
  publication-title: Nature
  doi: 10.1038/43448
– volume: 65
  start-page: 2179
  year: 2016
  ident: 18885_CR58
  publication-title: Diabetes
  doi: 10.2337/db15-1550
– volume: 111
  start-page: 1409
  year: 2003
  ident: 18885_CR26
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI200317490
– volume: 106
  start-page: 13100
  year: 2009
  ident: 18885_CR7
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0903723106
– volume: 67
  start-page: 296
  year: 2018
  ident: 18885_CR23
  publication-title: Diabetes
  doi: 10.2337/db18-296-LB
– volume: 282
  start-page: 1568
  year: 1999
  ident: 18885_CR14
  publication-title: J. Am. Med. Assoc.
  doi: 10.1001/jama.282.16.1568
– volume: 6
  start-page: 441
  year: 2010
  ident: 18885_CR67
  publication-title: Mol. Syst. Biol.
  doi: 10.1038/msb.2010.93
– volume: 48
  start-page: 1787
  year: 1999
  ident: 18885_CR43
  publication-title: Diabetes
  doi: 10.2337/diabetes.48.9.1787
– volume: 21
  start-page: 951
  year: 2013
  ident: 18885_CR45
  publication-title: Obesity
  doi: 10.1002/oby.20433
– volume: 60
  start-page: 1647
  year: 2011
  ident: 18885_CR16
  publication-title: Diabetes
  doi: 10.2337/db10-1791
– volume: 7
  year: 2017
  ident: 18885_CR33
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-16135-5
– volume: 37
  start-page: 936
  year: 2001
  ident: 18885_CR40
  publication-title: Hypertension
  doi: 10.1161/01.HYP.37.3.936
– volume: 94
  start-page: 8878
  year: 1997
  ident: 18885_CR9
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.94.16.8878
– volume: 165
  start-page: 249
  year: 2011
  ident: 18885_CR17
  publication-title: Eur. J. Endocrinol.
  doi: 10.1530/EJE-11-0252
– volume: 113
  start-page: 400
  year: 2019
  ident: 18885_CR57
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2018.10.012
– volume: 39
  start-page: 601
  year: 2010
  ident: 18885_CR4
  publication-title: Wei Sheng Yan Jiu
– volume: 8
  start-page: 192
  year: 2015
  ident: 18885_CR65
  publication-title: Circ. Cardiovasc. Genet.
  doi: 10.1161/CIRCGENETICS.114.000216
– volume: 34
  start-page: 4313
  year: 2018
  ident: 18885_CR79
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bty528
– volume: 108
  start-page: 6585
  year: 2011
  ident: 18885_CR28
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1015674108
– volume: 7
  year: 2016
  ident: 18885_CR73
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms11122
– volume: 269
  start-page: 543
  year: 1995
  ident: 18885_CR6
  publication-title: Science
  doi: 10.1126/science.7624777
– volume: 312
  start-page: R938
  year: 2017
  ident: 18885_CR39
  publication-title: Am. J. Physiol. Regul. Integr. Comp. Physiol.
  doi: 10.1152/ajpregu.00045.2016
– ident: 18885_CR51
  doi: 10.1210/clinem/dgaa251
– volume: 128
  start-page: 3237
  year: 2018
  ident: 18885_CR36
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI122042
– volume: 118
  start-page: 2583
  year: 2008
  ident: 18885_CR48
  publication-title: J. Clin. Investig.
– volume: 382
  start-page: 250
  year: 1996
  ident: 18885_CR49
  publication-title: Nature
  doi: 10.1038/382250a0
– volume: 43
  start-page: 1575
  year: 2011
  ident: 18885_CR63
  publication-title: Med. Sci. sports Exerc.
  doi: 10.1249/MSS.0b013e31821ece12
– volume: 98
  start-page: E491
  year: 2013
  ident: 18885_CR41
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2012-3009
– volume: 4
  start-page: bvz022
  year: 2020
  ident: 18885_CR52
  publication-title: J. Endocr. Soc.
  doi: 10.1210/jendso/bvz022
– volume: 99
  start-page: E2529
  year: 2014
  ident: 18885_CR59
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2014-2774
– volume: 1
  start-page: 754
  year: 2019
  ident: 18885_CR25
  publication-title: Nat. Metab.
  doi: 10.1038/s42255-019-0095-y
– volume: 346
  start-page: 570
  year: 2002
  ident: 18885_CR31
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa012437
– volume: 74
  start-page: 426
  year: 2001
  ident: 18885_CR60
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/74.4.426
– volume: 11
  year: 2020
  ident: 18885_CR69
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-13770-6
SSID ssj0000391844
Score 2.5551672
Snippet Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not...
Leptin treatment is effective to reduce body weight in animal models, but patients with obesity and associated hyperleptinemia do not respond well to leptin...
SourceID doaj
pubmedcentral
proquest
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 5145
SubjectTerms 631/443/319
692/163/2743
82/16
82/58
Humanities and Social Sciences
multidisciplinary
Science
Science (multidisciplinary)
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS8MwFA8yELyInzi_iOBNi20-1vSo4hiinjbwFtImweHMZG0P_ve-pN1YPehF6Kl9oc3LS97v9X0hdAkazmhmeZTohEdMGAbn4CCLAIpzQb3Oin2i8PPLYDRhj6_8da3Vl48Ja8oDN4y7EaBhhAYDLi9AtSuft6k5MzG1xCRUhTRf0HlrxlQ4g2kGpgtrs2RiKm5KFs4Eby0lYPXxKOtoolCwv4Myf8ZI_nCUBv0z3EHbLXDEt80H76IN4_bQZtNK8msfjZ98eIrDwftdYhNS-vDUVerdYOU0tqrCH4CUcV5X2M2rJYkv8e_d1vXCADmeGeVwWef-90x5gCbDh_H9KGo7JkQFE1kVAThJrfa5q6kFQ0pZrlVqs9Ry4KECsERzmoNSTjkvMjswqSbWxolS1FASA3Q5RD03d-bIhzyxnGcFU4woZglTROhEpDrWhjEuTB8lS-7Joi0n7rtazGRwa1MhG45L4LgMHJdZH12txnw2xTR-pb7zi7Ki9IWwww0QD9mKh_xLPProYrmkEjaO94YoZ-Z1KYmvzEYB7pA-Sjtr3Xlj94mbvoUS3MBAAJYw8nopFbLd--UvMzr-jxmdoC0SpBgueop61aI2ZwCMqvw87IFv_akGWw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS-QwEA-ecnAvh1-H66lEuDct1-Zjmz6u4iKL-nIK-xbSJjkXNSu2-3D__c1k24WKLAh9aie0nUwyv2RmfiHkF3g4Z4WXSWYzmQjlBMyDwyIBKC4VR5-VYqHw7d3w-kFMpnK6QVhXCxOT9iOlZZymu-yw37WIQxoXOxks2mRSfCFbSNUOtr01Gk3-TFY7K8h5roRoK2RSrj5o3PNCkay_hzDf50e-C5JG3zPeJt9b0EhHy8_cIRsu7JKvy2Mk_-2R-xtMTQk0Rr5r6mI5H52Fxjw5aoKl3jT0BVAyLRcNDfOmE0F6fwxZgx5AnD47E2i9KHFrpt4nD-Or-8vrpD0tIamEKpoEgEnuLdat5h4WUcZLa3Jf5F5KZQ0AJV7yEhxyLmVV-KHLLfM-zYzhjrMUYMsPshnmwR1gupMoZVEJI5gRngnDlM1UblPrhJDKDUjWaU9XLZU4nmjxrGNImyu91LgGjeuocV0MyNmqzeuSSGOt9AV2ykoSSbDjjfnbX90ahVYAPpSFtX1ZAeozWNJrpXAp98xl3KgBOe26VMOgwUiICW6-qDVDVjYOUIcNSN7r694b-0_C7DHSb4MCAVRCy_POKnQ77us1f3T4OfGf5BuL9goXPyKbzdvCHQP8acqT1t7_A97s_hU
  priority: 102
  providerName: Springer Nature
Title Leptin alters energy intake and fat mass but not energy expenditure in lean subjects
URI https://link.springer.com/article/10.1038/s41467-020-18885-9
https://www.proquest.com/docview/2451131292
https://pubmed.ncbi.nlm.nih.gov/PMC7553922
https://doaj.org/article/84158d742bc143a7890d54e03f2e13a8
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ra9swEBd9MNiX0b1Y9gga7NvmzdYjkj-MkYZmJaxlbA3km5AtaStNlS22of3vd5LtgkspA2ODffLjpPP9Tqe7Q-gdaDhrmONJZjKeMGkZ_AcneQJQnEsadFYaAoVPTifHS7ZY8dUO6ssddQys7jTtQj2p5Xb98erv9RcQ-M9tyLj8VLEo7sEQysCg40m-i_ZBM4lQ0eCkg_vxz0xzMGiCo5mkLEuAgHZxNHffZqCrYkr_AQ69vYrylis1aqj5AXrUQUs8bcfCY7Rj_RP0oC02ef0UnX0LC1g8jv7xCtsY9IfPfa0vLNbeYKdrfAlYGhdNjf2m7klCEYDg2G62Fsjx2mqPq6YIEzjVM7ScH53NjpOupkJSMpnXCcAX4UyIbhUOTC3tuNHC5cJxLo0GOEULWoDaFpyXuZtYYYhzaaY1tZSkAG6eoz2_8fZFWBTFCp6XTDOimSNME2kyKUxqLGNc2hHKeu6psks4HuperFV0fFOpWo4r4LiKHFf5CL2_afOnTbdxL_Vh6JQbypAqO57YbH-pTvKUBIgijWCkKAEb6hD4azizKXXEZlTLEXrbd6kC0Qr-Eu3tpqkUCbnbKAAiMkJi0NeDJw6v-PPfMUk3MBCgJ7T80I8K1Q_ue77o5X-8zCv0kMRBCht9jfbqbWPfADKqizHaFSsBezn_Okb70-ni5wKOh0en33_A2dlkNo5zDuMoFv8AxZkMtA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VIgSXqrzEUgpG4gYRiR-Jc4QV1QLbnrZSb5YT27SieFGTPfDvmfEmK6VClZBySsZKMh57PntmPgO8Qw_nnQwqK1yhMqm9xHmwrDOE4koL8lk5FQqfnpWLc_ntQl3sAR9rYVLSfqK0TNP0mB32sZNpSNNip8BFm8rqe3AfsXZJljwv57t9FWI811IO9TG50P9oOvFBiap_gi9vZ0feCpEmz3NyCAcDZGSfth_5GPZ8fAIPtodI_nkKqyUlpkSW4t4d86mYj13F3v70zEbHgu3ZL8TIrNn0LK77UYTI_SlgjVpAcXbtbWTdpqGNme4ZnJ98Wc0X2XBWQtZKXfcZwpIqOKparQIuoWxQzlahroJS2lmESaIRDbrjSqm2DqWvHA8hL6wVXvAcQctz2I_r6F9QspNsVN1KK7mVgUvLtSt05XLnpVTaz6AYtWfagUiczrO4NimgLbTZatygxk3SuKln8H7X5veWRuNO6c_UKTtJosBON9Y3P8xgEkYj9NAOV_ZNi5jPUkGvU9LnInBfCKtn8HbsUoNDhuIgNvr1pjOcONkEAh0-g2rS15M3Tp_Eq8tEvo0KREiJLT-MVmGGUd_d8Ucv_0_8DTxcrE6XZvn17PsRPOLJdvESr2C_v9n4YwRCffM6Wf5fuf__qQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VrUBcEE-x5WUkbhBI7PHGOS6PVVlKhUQr9WY5sV0qWm_VZA_8e8beZKVUqBJSTsk4j7Gd-cYz8xngDVk4Z9HLrLCFzFA5pP_grMoIikslos3KY6Hw98PZ_jEuT-TJDsyGWpiUtJ8oLdNvesgO-9BimtLR2SnIaZNZ9f7S-luwS3i7wAnszufLn8vt6krkPVeIfZVMLtQ_bjCyRImwf4Qyr-dIXguUJvuzuA_3euDI5ptXfQA7LjyE25utJP88gqODmJ4SWIp-t8ylkj52Fjrz2zETLPOmYxeElFm97lhYdYNIpPiPYWvSBYmzc2cCa9d1XJ5pH8Px4svRp_2s3zEha1BVXUbgpPQ21q6Wnhwp46U1pa9KL6WyhsCSqEVNRrmUsqn8zJWWe58XxggneE7Q5QlMwiq4pzHlCWtZNWiQG_QcDVe2UKXNrUOUyk2hGLSnm55OPO5qca5TWFsovdG4Jo3rpHFdTeHtts3lhkzjRumPsVO2kpEIO51YXZ3qfmBoRQBEWfLv64aQn4llvVaiy4XnrhBGTeH10KWaJk6MhpjgVutW88jMJgju8CmUo74ePXF8JZz9ShTcpEACltTy3TAqdD_32xu-aO__xF_BnR-fF_rg6-G3Z3CXp6FLh3gOk-5q7V4QGurql_3Q_wuiVAIc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Leptin+alters+energy+intake+and+fat+mass+but+not+energy+expenditure+in+lean+subjects&rft.jtitle=Nature+communications&rft.au=Chrysafi%2C+Pavlina&rft.au=Perakakis%2C+Nikolaos&rft.au=Farr%2C+Olivia+M&rft.au=Stefanakis%2C+Konstantinos&rft.date=2020-10-13&rft.issn=2041-1723&rft.eissn=2041-1723&rft.volume=11&rft.issue=1&rft.spage=5145&rft_id=info:doi/10.1038%2Fs41467-020-18885-9&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon